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Abstract
mRNAs targeted by endonuclease decay generally disappear without detectable decay intermediates. The exception to this
is nonsense-containing human b-globin mRNA, where the destabilization of full-length mRNA is accompanied by the
cytoplasmic accumulation of 59-truncated transcripts in erythroid cells of transgenic mice and in transfected erythroid cell
lines. The relationship of the shortened RNAs to the decay process was characterized using an inducible erythroid cell
system and an assay for quantifying full-length mRNA and a truncated RNA missing 169 nucleotides from the 59 end. In cells
knocked down for Upf1 a reciprocal increase in full-length and decrease in shortened RNA confirmed the role of NMD in this
process. Kinetic analysis demonstrated that the 59-truncated RNAs are metastable intermediates generated during the
decay process. SMG6 previously was identified as an endonuclease involved in NMD. Consistent with involvement of SMG6
in the decay process full-length nonsense-containing b-globin mRNA was increased and the D169 decay intermediate was
decreased in cells knocked down for SMG6. This was reversed by complementation with siRNA-resistant SMG6, but not by
SMG6 with inactivating PIN domain mutations. Importantly, none of these altered the phosphorylation state of Upf1. These
data provide the first proof for accumulation of stable NMD products by SMG6 endonuclease cleavage.
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Introduction
Endonuclease decay was thought to play a minor role in mRNA
turnover before results from deep sequencing showed widespread
evidence for endonuclease cleavage throughout the mammalian
mRNA transcriptome [1,2]. Despite this relatively little is known
about the enzymes that generate these cleavages, and only a few
bona fide mRNA endoribonucleases have been identified and
characterized [3]. A major complication to the study of
endonuclease-mediated mRNA decay is the rapidity with which
cleavage products are cleared by 59-39 and 39-59 exonucleases [3].
For the most part decay intermediates are only detected by
knocking down Xrn1 to stabilize the downstream fragment [4] or
by PCR amplification after ligating a primer to the newly formed
39 ends of cleavage products [5]. A possible exception to this is the
decay of nonsense-containing b-globin mRNA in erythroid cells.
In 1989 Lim and Maquat [6] showed that 59-truncated forms of
human b-globin mRNA accumulate in erythroid cells of mice that
are transgenic for several nonsense containing alleles. The same
59-truncated RNAs accumulate in murine erythroleukemia cells
that are stably transfected with wild type and nonsense-containing
human b-globin genes [7,8]. We showed previously that these
shortened RNAs were generated by endonuclease cleavage [7],
but because they were only seen in erythroid cells it was unclear if
these are intermediates in the decay process or the products of a
cell type-specific processing that is unique to b-globin mRNA in its
native cell environment. Complicating matters further the same
59-truncated RNAs were also seen in cells expressing wild type b-
globin mRNA, albeit at a much lower level [7], and their quantity
is increased by coexpressing Xenopus PMR1 in these cells [8]. This
was originally interpreted as evidence that erythroid cells employ a
PMR1-like endonuclease to degrade b-globin mRNA, but that
finding preceded the identification of SMG6 as an endonuclease
that catalyzes the degradation of nonsense-containing mRNA
[9,10].
Progress in studying endonuclease decay has been limited by the
challenges inherent in quantifying short-lived decay intermediates.
Thus, if the shortened forms of b-globin mRNA are indeed decay
intermediates we could take advantage of their appearance to
address several questions about the decay process. To address this
we developed an inducible line of erythroid cells which were used
to monitor the cytoplasmic appearance of full-length normal (WT-
hbG) and PTC-containing (PTC-hbG) human b-globin mRNA
after treating cells with doxycycline to induce transcription of their
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respective genes. Changes in full-length mRNA and one of the
59-truncated RNAs were determined using a modification
of Molecular Beacon Rapid Amplification of cDNA Ends
(MBRACE) [11], a qRT-PCR-based assay for quantifying
products after ligation of a common primer to uncapped 59 ends.
Materials and Methods
Plasmid Constructs
A wild type (WT) human b-globin gene and a gene with a
nonsense codon at position 60/61 (PTC60/61, [7]) were cloned
into a modified form of pcDNA3 (pcDNA3/TO) with a
tetracycline operator element upstream of the multiple cloning
site. Destabilized forms of each of these were generated by site-
directed mutagenesis of the nucleolin/a-CP binding site (H124
mutation) [12]. Plasmids expressing wild type and PTC-containing
TCRb mRNA (pAc/IF-TCRb) [13] were provided by Miles
Wilkinson. pcDNA3-HA-SMG6 and SMG6-m4 provided by
Oliver Mu¨hlemann were used for complementation experiments.
All of the primers described here and below are listed in Table S1.
Cell Culture
Murine erythroleukemia (MEL) cells that were stably transfect-
ed with wild type (Norm2) or nonsense-containing (Thal10) b-
globin genes were described previously [7]. Thal10 cells express a
form of b-globin mRNA with a single base deletion that results in a
nonsense codon at position 60/61 in the mature transcript. Norm2
and Thal10 cells were cultured in Minimal Essential Medium
alpha (alpha MEM) supplemented with 10% FBS, and b-globin
gene transcription was induced by treating for 48 hr with 1.5%
DMSO. K562 human erythroleukemia cells were obtained from
the American Type Culture Collection and cultured in the same
medium as Norm2 and Thal10 cells. A line of tetracycline
inducible K562 cells was generated by transduction with a
tetracycline repressor-expressing lentivirus (pLenti6/TR, Invitro-
gen). Transduction was performed by adding viral supernatant to
cells in a 24-well culture plate and centrifuging at 3006g for 2 hr,
25uC using a JS5.3 rotor in a Beckman Avanti J-20 XPI
centrifuge. 100 individual colonies were selected by growth for
14 days in medium containing 10 mg/ml blasticidin (Invitrogen)
and tested for tetracycline-regulated inducibility by electroporation
with pcDNA4/TO/LacZ and with inducible b-globin plasmids
and the one showing highest inducibility and tightest regulation
was selected for use in this study. Electroporation was performed
using a NeonH (Invitrogen) electroporator. 16106 cells were
centrifuged at 1006g for 4 min, the cell pellet was washed with
PBS and resuspended in 100 ml of buffer ‘T’ as per manufacturer’s
protocol. 3 mg of plasmid DNA was added and electroporation
was performed with a 100 ml tip using 2620 millisecond pulses of
1300 volts.
siRNA Knockdowns
For the experiments in Figs. 3 and 5, 16106 tet-inducible K562
cells electroporated with plasmids expressing inducible forms of b-
globin mRNA (WT or PTC60/61) or constitutively expressed
forms of T cell receptor (TCR) b (WT or PTC) plasmids were
cultured for 16 hr in antibiotic-free medium. The recovered cells
were resuspended in 750 ml Accell siRNA delivery media
(Thermo, Cat# B-005000). 100 mM solutions of control (Thermo,
D-001950-01), Upf1 (Thermo, E-011763-00-0005) or SMG6
(Thermo, E-017845-00-0005) SMARTpool siRNAs were pre-
pared in 16siRNA buffer (Cat# B-002000-UB-100). 7.5 ml of the
100 mM siRNA solution was added to cells in siRNA delivery
media and 100 ml aliquots were placed into individual wells in a
96-well plate. The next day cells were transferred to individual
wells of a 24-well plate, and b-globin was induced 48 hr after
knockdown by treating for 6 hr with 1 mg/ml doxycycline. A
SMG6 siRNA (59 GCUGCAGGUUACUUACAAG 39 with 39
UU overhangs) was generated that corresponds to the shRNA
target in [10]. In the experiment in Figure 6 26106 tetracycline-
inducible K562 cells were electroporated with 10 nM of control or
SMG6 siRNA in 100 ml of buffer ‘R’. The same cells were
electroporated 24 hr later with 10 nM of corresponding siRNA,
20 mg of WT- or PTC-hbG-expressing plasmid, and 20 mg of
empty vector, SMG6-expressing plasmid pcDNA3-HA-SMG6 or
SMG6 plasmid with the 3 catalytic aspartate residues in the PIN
domain changed to asparagine (SMG6-m4, [10]). b-globin gene
transcription was induced 16 hr later by adding 1 mg/ml
doxycycline to the medium and cytoplasmic RNA was isolated
6 hr after induction. Western blotting was used to determine the
effectiveness of knockdown, modified MBRACE assay was used to
monitor full-length and D169 RNA, and TCRb mRNA was
assayed by qRT- PCR.
Isolation of Cytoplasmic RNA and Protein
Cell were harvested by centrifugation and washed twice with ice
cold PBS. Norm2 and Thal10 cells were resuspended in lysis
buffer containing 0.1 M NaCl, 10 mM Tris-HCl pH 8.0, 2 mM
EDTA, 1% NP-40, 1% 2-mercaptoethanol, 1 mM dithiothreitol,
and 80 units/ml RNaseOUT. K562 cells were resuspended in
modified lysis buffer containing 0.15 M NaCl, 50 mM Tris-HCl
pH 7.5, 10 mM KCL, 10 mM MgCl2, 0.2% NP-40, 2 mM
dithiothreitol and 80 units/ml RNaseOUT. These were placed on
ice for 5 min, the tubes were gently flicked and incubated on ice
for an additional 5 min. The lysates were centrifuged at 50006g at
4uC for 10 min to pellet the nuclei, supernatant (cytoplasmic)
fractions were transferred to chilled microcentrifuge tubes and
RNA was extracted using Trizol Reagent (Life Technologies) as
recommended by the manufacturer’s protocol. Cell lysate was
used directly for protein quantification and visualization by
western blot analysis.
Antibodies
Affinity-purified rabbit polyclonal antibody to the tetracycline
repressor protein was obtained from MoBiTec. Rabbit polyclonal
antibodies to hUpf1 and hSMG6 were provided by Jens Lykke-
Andersen, and rabbit polyclonal anti-phosphoUpf1 was obtained
from Millipore, Inc. Antibody to ribosomal protein S6, horserad-
ish peroxidase (HRP)-coupled goat anti-rabbit IgG and goat anti-
mouse IgG were obtained from Santa Cruz Biotechnology.
Western Blot Analysis
Samples were denatured in 26 Laemmli sample buffer (Bio-
Rad Laboratories) with b-mercaptoethanol. 10 mg of cytoplasmic
protein was separated on 10% Mini-PROTEANH TGXTM
precast gels (Bio-Rad Laboratories) and transferred onto Im-
mobilonH-P PVDF membrane (EMDMillipore). Membranes were
blocked with 5% nonfat dry milk in Tris-buffered saline containing
0.05% Tween-20 (TBS-T), incubated with primary antibody
(1:1000 dilution) in the same solution, washed with TBS-T, then
incubated with horseradish peroxidase-coupled secondary anti-
body (1:10000 dilution). For experiments with anti-phospho-Upf1
antibody blots were blocked with 16TBS +3% BSA for 2 hr at
25uC. They were incubated overnight at 4uC in the same solution
with a 1:250 dilution of anti-phospho-Upf1 antibody and
secondary antibody incubation was performed in 16 TBS +3%
BSA. Membranes were developed with ECL-plus or for phospho-
Stable NMD Decay Intermediates
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Upf1 Western blotting a 1:1 mixture of ECL-prime solutions A
and B, and visualized on X-ray film (GeneMate).
S1 Nuclease Protection Assay
S1 nuclease protection assay was performed as described in
[14]. RNA was dissolved in S1 hybridization buffer (80%
formamide, 40 mM PIPES, pH6.4, 0.4 M NaCl, 1 mM EDTA)
and incubated overnight at 52uC with 3–56104 dpm of [32P]-end-
labeled antisense DNA probe. The antisense probe was obtained
by asymmetric PCR using the human b-globin cDNA plasmid
pSPkbC or the mouse b-actin cDNA plasmid pBSbactin as
templates. T4 polynucleotide kinase was used to label the 59 end of
the antisense b-globin primer HBB-AS: beginning at position 250,
primer 1249: beginning at position 346 and the antisense b-actin
primer YO-41 with c-[32P] ATP (3,000 Ci/mmol). The unlabeled
b-globin sense primer (HBB-S) and b-actin sense primer (ACT-S)
correspond to sequences just upstream of the b-globin or b-actin
cDNA in the expression plasmid. The [32P] labeled probe
generated by this reaction was purified by electrophoresis on a
6% polyacrylamide/urea gel. After hybridization, S1 nuclease
solution (0.28 M NaCl, 0.05 M sodium acetate, pH 5.2, 4.5 mM
ZnSO4, 20 mg/ml sheared salmon sperm DNA, 100 units S1
nuclease, Invitrogen) was added to each reaction and the mixture
was incubated at 28uC for 2 hr. Samples were precipitated with
ethanol and electrophoresed on denaturing 6% polyacrylamide/
urea gels. Protected fragments were visualized and quantified by
PhosphorImager.
MBRACE, Modified MBRACE and qRT-PCR Assays
1 mg of DNase I-treated cytoplasmic RNA was incubated with 3
units of tobacco acid pyrophosphatase (TAP, Epicentre) at 37uC
for 2 hr in 16 TAP buffer. An RNA adapter (RNA ADP) was
ligated to this using T4 RNA ligase I (New England Biolabs) in T4
RNA ligase reaction buffer supplemented with 1 mM ATP at
37uC for 2 hr. cDNA was prepared using SuperScriptH III first-
strand synthesis system (Life Technologies) and the product was
purified using QIAquickH PCR purification columns (Qiagen).
Approximately 20 ng of cDNA was used per qPCR reaction
containing 500 nM forward (MBRACE-F) and reverse primers
(HBB-FL-R1, HBB-D169-R1), 250 nM molecular beacon (HBB-
FL-MB, HBB-D169-MB) in 16 PerfeCTa qPCR FASTmix
(Quanta Biosciences). PCR was performed using an Eco Real-
Time PCR system (IlluminaH) and the following thermal profile:
95uC for 3 min, [95uC 10 sec, 61uC 30 sec with signal detection,
72uC 15 sec] for 40 cycles. Ct baseline and threshold were
automatically determined by Eco software. Molecular beacons
were designed to the junction sequence between the RNA adapter
and full-length or D169 b-globin mRNA. HEX-BHQ1 and
6FAM-Dabcyl fluorophore-quencher pairs were used to label the
full-length and decay product beacons respectively. HPLC purified
beacons were resuspended in 16 TE (10 mM Tris-HCl pH 8.0,
1 mM EDTA) buffer and stored in aliquots at 280uC. Modified
MBRACE assay used primers designed to the junction between
the ligated adapter RNA and full-length (HBB-JS-F) and D169
(HBB-D169 -JS-F) RNA. b-globin specific primers (HBB-FL-R1,
HBB-D169-R1 in MEL, HBB-FL-R2, HBB-D169-R2 in K562)
were designed to generate similar length products that could be
verified by gel electrophoresis. The locations of these primers on
hbGmRNA are shown in Figure S1. Reaction conditions to detect
full-length b-globin and its decay product were as follows: 20 ng
cDNA, 375 nM junction-specific and reverse primers in 16SYBR
Green PCR Master Mix (Applied Biosystems/Life Technologies)
in 10 ml reaction volume. The control mRNA TCRb (TCRb-F,
TCRb-R), GFP (emGFP-F, emGFP-R), and b-actin (MA-F,
MA-R) levels were also quantified by similar method using
indicated primers. qPCR was performed on the Eco Real Time
PCR system with thermal profiles for all SYBR Green reactions as
follows: 95uC for 10 min, [95uC for 10 sec, 60uC 30 sec with
signal detection] for 40 cycles followed by a melt curve. ROX
present in master mix acted as well-to-well normalization control.
The Eco software automatically determined Ct baseline and
threshold. To determine the fold change in transfection experi-
ments, b-globin mRNA levels were normalized to the levels of co-
transfection control GFP mRNA. In MEL cells b-globin mRNA
levels were normalized to b-actin mRNA.
Data Analysis
Experiments were conducted in biological triplicate and qPCR
reactions were performed in sample triplicate. Ct values for each
replicate were averaged, DCt was calculated by subtracting the
control (b-actin or GFP) Ct from the sample Ct. DCt values were
averaged over the replicates and the average DCt for WT b-globin
acted as the reference value. The DDCt value was calculated by
subtracting the DCt of WT from the sample DCt value. Fold
expression was calculated using the 2‘-DCt method [15].
Statistical analysis was performed using JMP9 (SAS, North
Carolina) software. Data distribution and variance determined
the appropriate method of analysis, all of which were performed 2-
tailed with an a=0.05. Graphs were generated using GraphPad
Prism 5 (GraphPad Software, Inc.) and bars represent standard
deviation.
Results
Actinomycin D Chase Shows Prolonged Presence of 59
Truncated RNAs in the Erythroid Cell Cytoplasm
Our previous work used murine erythroleukemia cells that were
stably transfected with WT-hbG (Norm2) or PTC-hbG (Thal10)
transgenes to study b-globin mRNA decay [7,8]. Using Actino-
mycin D and Northern blotting we showed that full-length wild
type mRNA has a half-life of 12 hr in Norm2 cells and PTC-
containing mRNA decays with biphasic kinetics and a half-life of
100 min [8]. Neither of the earlier studies looked at the fate of the
59-truncated RNAs, and because these are more abundant in
Thal10 cells we repeated Actinomycin D chase but this time used
S1 nuclease protection to monitor changes in full-length and 59-
truncated RNAs (Figure 1). Again, full-length PTC-hbG mRNA
showed a biphasic curve similar our previous results and to PTC-
hbG mRNA in non-erythroid cells [16]. Although they appeared
to be more stable than full-length mRNA there were differences in
the patterns seen for each of the 59-truncated RNAs. The
transcripts whose 59 ends were closest to that of full-length mRNA
disappeared at a faster rate than those whose 59 ends were further
away. Although it does not constitute proof, this is consistent with
multiple endonuclease cleavage events happening over time until a
limit digest is reached.
A Quantitative Assay for Full-length and 59-truncated b-
globin RNAs
Given the challenge presented by the prolonged presence of 59-
truncated RNAs we sought an alternative approach for studying
hbG mRNA decay in erythroid cells. The first step involved the
development of a method for quantifying full-length mRNA and
one of the truncated transcripts, and for this we selected Molecular
Beacon Rapid Amplification of cDNA Ends (MBRACE) [11]
(outlined in Figure 2A). In this assay, cytoplasmic RNA is first
treated with a phosphatase to prevent adapter ligation to uncapped
ends. The cap is removed with tobacco acid pyrophosphatase
Stable NMD Decay Intermediates
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(TAP), an RNA adapter is ligated onto the newly created 59-
monophosphate ends and the products are quantified using
junction-specific molecular beacons as indicated in the figure or
by qRT-PCR. Results in the left and middle panels of Figure 2B
comparing untreated with TAP-treated RNA demonstrate the
importance of removing the cap for MBRACE assay of full-length
WT- and PTC-hbG mRNAs.
A similar approach was then developed for quantifying one of
the 59-truncated RNAs shown in the right panel of Figure 2C. 59-
RACE that was performed using TAP-treated RNA from PTC-
hbG-expressing Thal10 cells and individual cloned products were
sequenced to confirm that the junction with the ligated adapter
matched each of the 59 ends identified in [7] by primer extension
and S1 nuclease protection. The transcript with 59 end at position
169 (D169) was then selected for assay development. Our
discovery of cytoplasmic capping [17] was the result of following
an earlier report describing the 59 ends of the truncated RNAs as
having a cap or cap-like structure [18]. The presence of a cap on
59-truncated RNAs is evident in the right panel of Figure 2B,
where TAP treatment of RNA from PTC-hbG-expressing cells
resulted in an almost 800-fold increase in signal for D169 RNA.
Finally, the applicability of MBRACE assay for quantifying
changes in full-length and D169 RNA was confirmed by the
comparable results obtained by MBRACE assay (Figure 2D) and
S1 nuclease protection (Figure 2C) performed with RNA from
MEL cells expressing WT- and PTC-hbG mRNA.
NMD is Responsible for the Increase in 59 Truncated
RNAs from PTC-hbG mRNA
Although K562 cells are an erythroid cell line they do not
express hbG mRNA. We developed a line of tetracycline inducible
K562 cells to circumvent complications resulting from the
prolonged cytoplasmic lifetime of 59-truncated RNAs. In each of
the following experiments these cells were electroporated with
plasmids expressing tetracycline inducible full-length WT- and
PTC-hbG genes, and changes in full-length and D169 RNA were
quantified by MBRACE assay after inducing their transcription
with doxycycline. In the experiment in Figure 3 electroporated
K562 cells were treated with AccellH control or Upf1 siRNAs
before inducing WT- or PTC-hbG mRNA. This reduced Upf1 to
10% of control (Figure 3A), and the stabilization of nonsense-
containing TCRb mRNA (Figure 3B) demonstrated its effective-
ness in inactivating NMD. Knocking down Upf1 had little impact
on WT-hbG mRNA or the amount of D169 RNA in cells
expressing WT-hbG mRNA; however, the stabilization of full-
length PTC-hbG mRNA and reduction in the level of D169 RNA
to that observed with WT-hbG (Figure 3C and D) confirm that
NMD is responsible for the increased appearance of 59-truncated
transcripts from PTC-hbG mRNA.
The 59 Truncated RNAs are Metastable Decay
Intermediates
The prolonged cytoplasmic residence of 59-truncated RNAs
after Actinomycin D (Figure 1) ruled out the use of transcription
inhibitors in determining whether these are intermediates of PTC-
hbG decay. Instead we monitored the appearance of both forms of
hbG mRNA over time after inducing transcription of their
respective WT- and PTC-hbG genes (Figure 4). If the truncated
RNAs are decay intermediates the expectation is their appearance
in the cytoplasm should follow that of full-length mRNA. Changes
in each transcript over 12 hr after induction are shown in
Figure 4A, and the first 3 hr after induction, where initial
differences are more evident, are shown enlarged in (Figure 4B).
The appearance of D169 RNA after full-length WT- and PTC-
hbG mRNA is consistent with assignment of the shortened RNAs
as intermediates in the decay process.
To obtain more definitive evidence of this we looked for a way
to accentuate the differences in time of appearance of full-length
and D169 RNA that was compatible with the inducible cell system.
To address this we took advantage of the fact that given the same
degree of induction an mRNA that turns over rapidly will reach a
new steady state sooner than one with a slower rate of decay [19].
The prolonged stability of hbG mRNA (and possibly the 59
truncated transcripts) is due in part from the binding of nucleolin
to a site in the 39-UTR [12]. In the experiment in Figure 4C the
time course appearance of the different RNAs was repeated using
WT- and PTC-bG genes with inactivated nucleolin binding sites
(H124, [12]. As anticipated, this reduced the degree to which of
each mRNA accumulated; however, it provided clear and
convincing evidence of differences in the time of appearance of
full-length and D169 RNAs. Taken together with results in [7,8]
Figure 1. Prolonged cytoplasmic residence of 59-truncated
forms of PTC-hbG mRNA. A. Actinomycin D (6 mg/ml) was added to
DMSO-induced Thal10 cells at time 0 and cytoplasmic RNA recovered at
the indicated times was assayed by S1 nuclease protection using a
probe for the first 354 nt of b-globin mRNA. Hinf I restriction fragments
of QX174 DNA were used as size markers (M, lane 1) and the location of
each of the products relative to the 59 end of b-globin mRNA is
indicated on the right side of the autoradiogram. B. The amount of
each species was quantified by phosphorimager analysis and plotted on
the right as a function of time after addition of Actinomycin D.
doi:10.1371/journal.pone.0074791.g001
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these data confirm that the 59-truncated RNAs are endonuclease-
generated decay intermediates.
SMG6 is the Endonuclease that Generates 59-truncated
forms of PTC-hbG mRNA
We next sought to determine the identity of the endonucle-
ase responsible for generating the 59-truncated decay interme-
diates. Our previous work suggested this was PMR1 or a
PMR1-like endonuclease [7,8]. However this was ruled out by
the lack of any impact on WT- or PTC-hbG mRNA of
inhibiting PMR1 activation or overexpressing human PMR1
(Figure S2). SMG6 is a PIN-domain containing endonuclease
that participates in the degradation of nonsense-containing
mRNAs [9,10]. It lacks sequence selectivity, and specificity for
nonsense-containing mRNAs results from its binding to the
exon junction at the same site as Upf3b [20]. In the experiment
in Figure 5 K562 cells electroporated with plasmids expressing
WT- and PTC-hbG mRNA were knocked down for SMG6
before adding doxycycline to induce WT- and PTC-hbG
mRNA. Knockdown depleted ,90% of SMG6 (Figure 5A) and
this had the anticipated effect of stabilizing PTC-containing
TCRb mRNA (Figure 5B). SMG6 knockdown had no impact
on WT full-length or D169 RNA, increased full-length PTC-
hbG mRNA and returned the amount D169 RNA to the level
generated from WT-hbG mRNA.
Although these data are consistent with SMG6 generating
D169 RNA it was formally possible that the observed effects
were secondary to changes in Upf1 phosphorylation [21]. This
was first addressed by a complementation experiment similar
to that performed in [10]. In the experiment in Figure 6
tetracycline-inducible K562 cells were electroporated with
control or SMG6 siRNAs, then a second time with the same
siRNAs together with empty vector or plasmids expressing
siRNA-resistant SMG6 or an inactive form of SMG6 with the
Figure 2. Development of a modified MBRACE assay for quantifying full-length and one of the 59-truncated b-globin mRNAs. A. A
schematic of the modified MBRACE assay is shown, and the locations of each of the primers are presented in Figure S1. B. RNA from triplicate cultures
of MEL cells expressing WT-hbG or PTC-hbG mRNA was added directly to the ligation reaction with the 59 RNA adapter (–TAP, open bars) or treated
with tobacco acid pyrophosphatase (+TAP, grey bars) before ligation. Results obtained without TAP treatment were arbitrarily set to 1 and results
obtained with TAP-treated RNA were normalized to the 2TAP samples. The results represent the mean 6 standard deviation for triplicate samples.
*indicates p,0.01 by Student’s two-tailed T-test. C. S1 nuclease protection assay was used to demonstrate the increased accumulation of 59-
truncated RNAs in cells expressing PTC-hbG mRNA (lane 6) compared to WT-hbG mRNA (lane 3). The locations of each of the 59-truncated RNAs with
respect to the cap site are indicated to the right of each autoradiogram. D. The transcript beginning at position 169 nt (D169) was selected as a
representative truncated RNA. Cytoplasmic RNA from MEL cells expressing WT- or PTC-hbG mRNA was used to demonstrate applicability of the
modified MBRACE assay for quantifying changes in full-length mRNA and D169 RNA. In each graph the amount of RNA from each cell line was first
normalized to b-actin. Shown is the mean 6 standard deviation for biological triplicates, *indicates p,0.001 by two-tailed t-test.
doi:10.1371/journal.pone.0074791.g002
Stable NMD Decay Intermediates
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3 active site aspartic acid residues changed to asparagine
(SMG6-m4). The second round of transfection included
tetracycline-inducible plasmids expressing WT- and PTC-
hbG mRNA, and cells recovered 6 hr after induction were
analyzed by Western blotting for changes in SMG6 and by
modified MBRACE assay.
Figure 3. Evidence that NMD is responsible for the accumulation of D169 RNA from PTC2hbG mRNA. Tet-inducible K562 cells in
antibiotic-free medium were electroporated with plasmids expressing constitutive wild type or nonsense-containing TCRb genes, or each of the
inducible b-globin genes, and a GFP control. Sixteen hr later they were transfected with Accell SmartPoolR Upf1 or control siRNAs, cultured for an
additional 48 hr, then induced with doxycycline for 6 hr. A. Cytoplasmic extracts from WT- and PTC-hbG expressing cells were assayed by Western
blotting for efficiency of Upf1 knockdown. B. The effectiveness of Upf1 knockdown in inhibiting NMD was determined by qRT-PCR analysis of
changes in WT- versus PTC-TCRb mRNA. C. The modified MBRACE assay was used to quantify the impact of Upf1 knockdown on full-length WT- and
PTC-hbG mRNA. D. Modified MBRACE assay was used to monitor the impact of Upf1 knockdown on the production of D169 RNA. The results
represent the mean 6 standard deviation of triplicate cultures, *indicates p,0.05 by two-tailed Student’s T-test.
doi:10.1371/journal.pone.0074791.g003
Figure 4. Evidence that 59-truncated RNAs are decay intermediates. A. Doxycycline was added at time 0 to tet-inducible K562 cells that were
electroporated 16 hr earlier with plasmids bearing inducible WT- or PTC-hbG genes and a GFP control. Cytoplasmic RNA isolated at intervals over
12 hr of induction was analyzed by modified MBRACE assay for changes in full-length and D169 forms of hbG mRNA. B. The first 3 hr of induction is
shown enlarged. C. The experiment was repeated except that the plasmids that were electroporated into tet-inducible K562 cells expressed a
destabilized form of b-globin mRNA (H124 mutation) as a result of disruption of the 39-UTR nucleolin binding site [12]. Each point represents the
mean 6 standard deviation for triplicate determinations.
doi:10.1371/journal.pone.0074791.g004
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SMG6 knockdown reduced levels of the endogenous protein
to ,30% of control (Figure 6A, compare lane 3 with lanes 4
and 5), and in each transfectant siRNA-resistant SMG6 was
overexpressed compared to endogenous protein (Figure 6A,
compare lanes 1,2,6–9 with lane 3). The similar expression of
each form of recombinant SMG6 confirmed that each of these
is resistant to SMG6 siRNA and therefore capable of
complementing the impact of SMG6 knockdown on PTC-
hbG NMD. Results in Figure 6B show that neither SMG6
knockdown nor its complementation with exogenous SMG6 had
any impact on wild-type full-length or D169 RNA (grey bars).
As in Figure 5, SMG6 knockdown increased the amount of full-
length PTC-hbG mRNA and decreased the amount of D169
RNA (SMG6 siRNA+vector). This was reversed by co-
expression of siRNA-resistant SMG6, but not by co-expression
of catalytically-inactive SMG6-m4, thus confirming the identity
of SMG6 as the enzyme that is responsible for generating stable
decay products from PTC-hbG mRNA.
Altering SMG6 has no Impact on the Phosphorylation
State of Upf1
In Okada-Katsuhata et al. [21] NMD was inhibited by SMG6
knockdown or by overexpression of an inactive form of SMG6.
SMG6 functions in the dephosphorylation of Upf1, and in each
case this was reported to result from interference with the cycling
of Upf1 between phosphorylation states. The absence of an
inhibitory effect of SMG6m4 on PTC-hbG mRNA decay in
Figure 6B argued against this. Nevertheless, to be certain that the
results in Figs. 5 and 6 indeed demonstrate a direct role for SMG6
endonuclease activity in generating stable decay intermediates we
looked at the impact of each of these changes on the
phosphorylation state of Upf1. In the experiment in Figure 7
K562 cells were electroporated as in Figure 6 with control or
SMG6 siRNAs, and with empty vector or with plasmids expressing
SMG6 or SMG6-m4. Western blotting with anti-SMG6 antibody
(top panel) confirmed the effectiveness of each of these steps in
reducing or increasing each form of SMG6. Importantly, Western
blotting with an anti-phosphoUpf1 antibody showed that none of
these treatments had any impact on the phosphorylation state of
Upf1.
Discussion
To the best of our knowledge the 59-truncated forms of PTC-
hbG mRNA examined here are the only example of metastable
products of nonsense-mediated mRNA decay. They were first
identified in erythroid cells of mice expressing a nonsense-
containing transgene [6], and to date have only been detected in
erythroid cells. Like the parent mRNA the 59 ends of these RNAs
are capped [17,18] and they have an intact 39-poly(A) tail [7]. S1
nuclease protection assays performed on cytoplasmic RNA
recovered over 8 hr of actinomycin D treatment showed full-
length PTC-hbG mRNA decayed with biphasic kinetics (Figure 1)
Figure 5. SMG6 knockdown increases full-length PTC-hbG mRNA and decreases D169 RNA. Tet-inducible K562 cells in antibiotic-free
medium were electroporated as in Figure 3, with plasmids expressing constitutive WT- or PTC-TCRb genes, or each of the inducible hbG genes, and a
GFP control. Sixteen hr later they were transfected with Accell SmartPoolR SMG6 or control siRNAs, cultured for an additional 48 hr, then induced
with doxycycline for 6 hr. A. Cytoplasmic extracts from cells expressing each form of b-globin mRNA were assayed by Western blotting for efficiency
of SMG6 knockdown. B. The effectiveness of SMG6 knockdown in inhibiting NMD was determined by qRT-PCR analysis of changes in WT- versus PTC-
TCRb mRNA. C. The modified MBRACE assay was used to quantify the impact of SMG6 knockdown on full-length WT- and PTC-hbG mRNA. D.
Modified MBRACE assay was used to monitor the impact of SMG6 knockdown on the production of D169 RNA. The results represent the mean 6
standard deviation of triplicate cultures, *indicates p,0.05 by two-tailed Student’s t-test.
doi:10.1371/journal.pone.0074791.g005
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that resemble the decay of PTC-hbG mRNA in non-erythroid
cells [16]. The decay curves in Figure 1B indicated that the 59-
truncated RNAs disappear more slowly than full-length PTC-hbG
mRNA. However, the transcripts with 59 ends closer to the cap
appear to decay more quickly than transcripts whose 59 ends are
further from the cap, the result one might expect for RNA
undergoing multiple cleavage events until reaching some limit
digest. The complexity of this precluded the use transcriptional
inhibition to study the relationship of the 59-truncated transcripts
to PTC-hbG mRNA decay. This was instead addressed through
the use of an inducible erythroid cell line and a modification of the
MBRACE assay for quantifying changes in full-length mRNA and
one of the truncated RNAs (D169). In the course of qualifying this
assay we reaffirmed results in [17] showing the 59-truncated RNAs
are capped (Figure 2B).
Nonsense-containing mRNAs have been reported to undergo
deadenylation, decapping, 59-exonucleolytic decay, 39-exonucleo-
lytic decay and endonucleolytic decay [2,22]. The rules by which
any given mRNA selected for a particular degradation pathway
have not been determined. Results presented here confirm that
NMD is responsible for the decay of full-length PTC-hbG mRNA
and identify the 59-truncated RNAs as decay intermediates. Three
different experiments demonstrated that SMG6 is the endonucle-
ase that generates these intermediates. The first (Figure 5) looked
at the impact of SMG6 knockdown alone, and the most
straightforward interpretation of these data identifies SMG6 is
the enzyme that cleaves PTC-hbG mRNA to generate the stable
D169 intermediate. However, SMG6 has been reported to
function in the dephosphorylation of Upf1, and its knock down
in HeLa cells was reported to inhibit NMD secondary to the
accumulation of phospho-Upf1 [21]. To address this we
performed a complementation experiment in which we knocked
down SMG6 and expressed siRNA-resistant forms of SMG6 or
SMG6 with the 3 aspartic acid residues in the PIN domain
catalytic core changed to asparagine (SMG6-m4). Results in
Figure 6 show that expression of siRNA resistant SMG6 reversed
the effect of SMG6 knockdown on the generation of D169 RNA
from PTC-hbG mRNA, but expression of SMG6-m4 did not, thus
supporting the identification of SMG6 as the responsible
endonuclease.
Results in Figure 6 also brought to light a difference between
our results and those in [21] regarding the impact of overexpress-
ing inactive forms of SMG6. In that study NMD was inhibited by
overexpression of SMG6 with a single aspartate-to-alanine PIN
Figure 6. Complementation identifies SMG6 is the endonucle-
ase responsible for generating D169 RNA from PTC-hbGmRNA.
Tet-inducible K562 cells in antibiotic-free medium were electroporated
as in Figure 3, with control or SMG6 siRNAs. Twenty-four hr later they
were electroporated again with the same siRNAs plus empty vector or
plasmids expressing siRNA resistant SMG6 or a catalytically-inactive
form of SMG6 (SMG6-m4) and plasmids expressing each of the
inducible hbG genes. Doxycycline was added 16 hr later to induce
each of the hbG genes. A. Cytoplasmic extracts from triplicate cultures
were pooled and analyzed by Western blotting with anti-SMG6
antibody or with antibody to GAPDH. B. Cytoplasmic RNA from
individual cultures was analyzed by modified MBRACE assay for full-
length (upper panel) and D169 (lower panel) forms of hbG mRNA. The
results represent the mean 6 standard deviation of triplicate cultures,
*indicates p,0.05 by two-tailed Student’s t-test.
doi:10.1371/journal.pone.0074791.g006
Figure 7. Upf1 phosphorylation is unaffected by SMG6
knockdown or overexpression of inactive SMG6. Tet-inducible
K562 cells were electroporated as in Figure 6 with control or SMG6
siRNAs and empty vector, or plasmids expressing SMG6 or inactive
SMG6-m4. Cytoplasmic extracts recovered 16 hr after the second round
of electroporation were analyzed by Western blotting with antibodies
to SMG6 (top panel) or to phospho-Upf1 (middle panels). Both light and
dark exposures are shown. Ribosomal protein S6 was used as a loading
control (bottom panel).
doi:10.1371/journal.pone.0074791.g007
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domain mutation (D1251A). We saw no evidence for inhibition of
NMD with overexpression of SMG6-m4 in K562 cells. In Figure 6
each form of SMG6 was clearly overexpressed (Figure 6A);
however, as evident in the first 3 datasets in Figure 6B neither of
these had any impact on full-length or D169 RNA. We do not
know why these results differ from those in [21], but this may be
due to differences in the form of inactive SMG6 used in our study,
or to the fact that our experiments examined hbG mRNA in its
native cell context.
It remained formally possible that SMG6 knockdown still
resulted in the accumulation of phosho-Upf1 and expression of
SMG6-m4 just helped to keep Upf1 in the phosphorylated state.
This was ruled out by the results of Figure 7, where we saw no
evidence for changes in the phosphorylation state of Upf1
regardless of whether SMG6 was knocked down or an inactive
form of SMG6 was expressed in these cells. Together with the
preceding experiments these data provide proof that metastable
decay intermediates are generated by SMG6 cleavage of PTC-
hbG mRNA.
Finally, K562 cells do not natively express b-globin mRNA but
they do express detectable levels of d-globin mRNA [23]. In the
course of this work we identified a form of d-globin mRNA whose
59 end matched that of D169 RNA (Figure S1). This raised a
question that was not answered by this study; to wit, why are the
same 59-truncated RNAs also detectable in cells expressing WT-
hbG mRNA? These were seen in [7] and [8], and again here by
both S1 nuclease protection and by the modified MBRACE assay
(Figure 2). Although the endonuclease responsible for generating
these fragments has yet to be identified, the fact that both WT-
and PTC-hbG mRNA are cleaved at the same sites suggests
features of the mRNP play a major role in determining the
location of endonuclease cleavage sites.
Supporting Information
Figure S1 Sequence alignment of human beta- and
delta-globin mRNA and locations of MBRACE primers.
Human beta-globin (HBB) and delta-globin (HBD) mRNAs are
shown aligned. The yellow highlights identify the locations of
primers used to quantify full-length mRNA and the green
highlights identify the locations of primers used to quantify
D169 RNA. Note that the sequence at the 59 D169 primer binding
site is identical for beta- and delta-globin mRNA.
(TIF)
Figure S2 Impact of changes in PMR1 on full-length and
D169 hbG mRNA. A and B. Tet-inducible K562 cells
electroporated with inducible WT- and PTC-hbG genes were
treated with DMSO (vehicle), PP3 (an inactive analog of PP2), or
PP2 c-Src inhibitor to inactivate PMR1 targeting to polysomes
[24,25]. Cytoplasmic RNA recovered 6 hr after induction was
assayed by modified MBRACE for changes in full-length (A) and
D169 RNA (B). C and D. Tet-inducible K562 cells were
electroporated with WT- and PTC-hbG expressing plasmids
together with plasmids expressing GFP, active hPMR1 or inactive
hPMR1. Cytoplasmic RNA recovered 6 hr after induction was
analyzed by modified MBRACE for changes in full-length (C) and
D169 RNA (D). The results represent the mean 6 standard
deviation of triplicate cultures, *indicates p,0.05 by two-tailed
Student’s t-test.
(TIF)
Table S1 Oligonucleotides and primers.
(XLSX)
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